Syngene International Profit & Loss Annual

Trade
BSE: 539268 | NSE: SYNGENE | ISIN: INE398R01022 | Sector: Biotechnology & Drugs
895.25 +25.85 (2.97%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 3,488.603,192.902,604.202,184.30
Total Revenue 3,488.603,192.902,604.202,184.30
Costof Revenue Total 930.20929.40813.80583.90
Gross Profit 2,558.402,263.501,790.401,600.40
Selling/ General/ Admin Expenses Total 888.701,265.801,037.30933.40
Depreciation/ Amortization 425.90359.70305.20270.30
Unusual Expense( Income) 11.100.0030.70-35.00
Other Operating Expenses Total 599.5014.0011.8012.30
Total Operating Expense 2,855.402,575.702,203.301,769.10
Operating Income 633.20617.20400.90415.20
Interest Inc( Exp) Net- Non- Op Total -1,030.00-161.00835.00538.00
Other Net 90.60--0.20
Net Income Before Taxes 620.80593.60484.40469.20
Provisionfor Income Taxes 110.80129.2088.6064.30
Net Income After Taxes 510.00464.40395.80404.90
Net Income Before Extra Items 510.00464.40395.80404.90
Net Income 510.00464.40395.80404.90
Income Availableto Com Excl Extra Ord 510.00464.40395.80404.90
Income Availableto Com Incl Extra Ord 510.00464.40395.80404.90
Diluted Net Income 510.00464.40395.80404.90
Diluted Weighted Average Shares 40.1940.3640.2940.07
Diluted EPS Excluding Extra Ord Items 12.6911.519.8210.11
DPS- Common Stock Primary Issue 1.250.500.50-
Diluted Normalized EPS 12.9211.6510.459.35
Interest Exp( Inc) Net- Operating Total -68.0045.0042.00
Gain( Loss)on Saleof Assets --75.00--
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts